However, myeloid and T regulatory cells show significant difference only in tumor ROI, whereas proliferating and non-proliferating cytotoxic CD8+ T cells are significantly higher in MSI throughout all tissue ROIs. This evidence concerns the gene CD8A and neoplasm.